iPSC

ReNeuron’s iPSC platform has potential applications to generate CAR-T and/or CAR-NK cells and to produce Exosomes with the ability to target specific cells and tissues within the body.

Induced Pluripotent Stem Cell (iPSC)

Pluripotent stem cells are cells that have the capacity to self-renew and to develop into the three primary germ cell layers of the early embryo and therefore into any cell type.
Induced pluripotent stem cells or iPSCs are reprogrammed adult cells that have the same capacity.

ReNeuron’s iPSC Platform

New data has shown that ReNeuron’s proprietary human neural stem cell line (CTX) can be readily reprogrammed to pluripotency while maintaining its conditional immortalisation technology.
Allows for the rapid development of new allogeneic cell lines as cell-based therapeutics or for the production of exosomes with specific tissue targeting.
A number of different cell lines are currently being developed..
We continue to develop strong relationships with academic leaders in all areas of cell therapy to understand where the technology will have the greatest impact.
The maintenance of the immortalisation technology within the new exosome producer cell lines will allow for the scaled production of highly consistent exosomes at a scale relevant for clinical development.

iPSC's have the capacity to develop into any cell type.
There is a potential to produce exosomes with the ability to target specific tissues within the body.
Our iPSCs research platform provides further scope for a wide range of industry partnerships.